Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pacher

Showing results (41-50 of 1,015) with videos related to

Pageof 102
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|February 29, 2012
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegenerationPál Pacher, Ken Mackie
Arteriosclerosis, Thrombosis, and Vascular Biology|March 17, 2012
Regulation of macrophage function by adenosineGyörgy Haskó, Pál Pacher
Zeitschrift Fur Kardiologie|June 21, 2016
Prostaglandin E1 bridge to heart transplantation - methods, technique, resultsR Pacher, B Stanek
The Plant Journal : for Cell and Molecular Biology|December 28, 2016
From classical mutagenesis to nuclease-based breeding - directing natural DNA repair for a natural end-productMichael Pacher, Holger Puchta
Medical Hypotheses|October 17, 2001
Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channelsP Pacher, Z Ungvari
Progress in Lipid Research|February 8, 2011
Is lipid signaling through cannabinoid 2 receptors part of a protective system?P Pacher, R Mechoulam
Nature Medicine|July 2, 2004
Cannabinoids cool the intestineGeorge Kunos, Pál Pacher
The American Journal of Pathology|June 7, 2008
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human diseasePal Pacher, Csaba Szabo
American Journal of Physiology. Heart and Circulatory Physiology|January 22, 2008
Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseasesPál Pacher, Zoltán Ungvári
Cardiovascular Drug Reviews|October 9, 2007
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitorsPál Pacher, Csaba Szabó
Pageof 102

Showing results (41-50 of 1,015) with videos related to

Sort By:
Pageof 102
Journal of Molecular Medicine (Berlin, Germany)|February 29, 2012
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegenerationPál Pacher, Ken Mackie
Arteriosclerosis, Thrombosis, and Vascular Biology|March 17, 2012
Regulation of macrophage function by adenosineGyörgy Haskó, Pál Pacher
Zeitschrift Fur Kardiologie|June 21, 2016
Prostaglandin E1 bridge to heart transplantation - methods, technique, resultsR Pacher, B Stanek
The Plant Journal : for Cell and Molecular Biology|December 28, 2016
From classical mutagenesis to nuclease-based breeding - directing natural DNA repair for a natural end-productMichael Pacher, Holger Puchta
Medical Hypotheses|October 17, 2001
Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channelsP Pacher, Z Ungvari
Progress in Lipid Research|February 8, 2011
Is lipid signaling through cannabinoid 2 receptors part of a protective system?P Pacher, R Mechoulam
Nature Medicine|July 2, 2004
Cannabinoids cool the intestineGeorge Kunos, Pál Pacher
The American Journal of Pathology|June 7, 2008
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human diseasePal Pacher, Csaba Szabo
American Journal of Physiology. Heart and Circulatory Physiology|January 22, 2008
Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseasesPál Pacher, Zoltán Ungvári
Cardiovascular Drug Reviews|October 9, 2007
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitorsPál Pacher, Csaba Szabó
Pageof 102